Day One Biopharmaceuticals Overview

Day One Biopharmaceuticals Cost of Revenue

Cost of Revenue analysis for DAWN.

Quarterly Cost of Revenue

$6.08M

↑ 103.92% YoY

As of Dec 31, 2025

Annual Cost of Revenue (TTM)

$17.21M

↑ 219% YoY

Trailing 12 months ending Dec 31, 2025

Average Cost of Revenue (Comparison Companies)

Cost of Revenue History

Cost of Revenue Comparison

Annual Cost of Revenue Growth Rate (%)

Annual Cost of Revenue Growth (Absolute)

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin